Amylin Pharmaceuticals (AMLN) is a biopharmaceutical company focusing on the diabetes and other metabolic diseases through the discovery, development and commercialization of medicines. This stock is trading up 11.5% at $25.58 in recent trading.
Today's Volume: 9.7 millionAverage Volume: 5.15 million
Volume % Change: 207% >>5 Big Stocks to Trade or Gains Shares of AMLN are surging higher today after a report hit the wires that the company is reaching out to potential buyers about a possible sale. Reuters said that AMLN is looking for buyers and has hired Credit Suisse and Goldman Sachs as financial advisers. From a technical perspective, AMLN is gapping up sharply today on monster volume. This move is quickly pushing the stock within range of triggering a big breakout trade. That trade will hit once AMLN can manage to move or close above some near-term overhead resistance at $25.84 with high-volume. Traders should now look for long-biased traders in AMLN as long as this stock is trending above $25.84 with strong upside volume flows. I would consider any upside volume day that registers near or above 5.15 million shares as strong. Look for AMLN to close near or above its daily high today of $25.96 as a sign that the upside momentum will continue in the short-term. A possible target is $30 if we get a strong close, and we continue to see AMLN trending above $25.84 with strong upside volume flows.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts